Evonik Industries (FRA:EVK) has been assigned a €27.00 ($32.14) price objective by equities researchers at UBS in a research note issued to investors on Thursday, www.boersen-zeitung.de reports. The brokerage currently has a “sell” rating on the stock. UBS’s price objective suggests a potential downside of 15.97% from the stock’s current price.

A number of other research firms have also commented on EVK. Deutsche Bank set a €40.00 ($47.62) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Monday. Goldman Sachs Group set a €29.00 ($34.52) target price on Evonik Industries and gave the company a “neutral” rating in a report on Wednesday, October 11th. Nord/LB set a €31.00 ($36.90) target price on Evonik Industries and gave the company a “neutral” rating in a report on Friday, November 3rd. DZ Bank restated a “neutral” rating on shares of Evonik Industries in a report on Friday, November 3rd. Finally, Kepler Capital Markets set a €31.00 ($36.90) price objective on Evonik Industries and gave the stock a “neutral” rating in a report on Thursday, October 5th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of €33.75 ($40.18).

Shares of Evonik Industries (FRA:EVK) opened at €32.13 ($38.25) on Thursday. Evonik Industries has a 1-year low of €25.74 ($30.64) and a 1-year high of €32.97 ($39.25).

COPYRIGHT VIOLATION WARNING: This story was first posted by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/07/evonik-industries-evk-given-a-27-00-price-target-at-ubs.html.

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with MarketBeat.com's FREE daily email newsletter.